Skip to main content
SpringerLink
Log in

Antiparkinsonian effect of flupirtine in monoamine-depleted rats

  • Published:
Journal of Neural Transmission Aims and scope Submit manuscript

Summary

Excitatory amino acid receptor antagonists lead to marked suppression of parkinsonian-like symptoms in rodent and primate models of Parkinson's disease and are able to potentiate the ability of L-DOPA to reverse akinesia and ameliorate muscular rigidity displayed in these animal models. Flupirtine, which is clinically used as a non-opioid analgesic agent, has some N-methyl-D-aspartate (NMDA) antagonistic properties in several in vivo and in vitro experiments. We now report that in monoamine depleted rats (pretreated with reserpine, 5 mg/kg, and α-methyl-para-tyrosine, 250mg/ kg i.p.) flupirtine dose-dependently (1–20mg/kg i.p.) suppressed rigidity, measured as tonic EMG activity in the gastrocnemius muscle, but had no effect on akinesia, measured as locomotor activity. In addition, it potentiated the antiparkinsonian effect of L-DOPA on akinesia and rigidity in this rodent model of Parkinson's disease. These effects of flupirtine are of particular clinical relevance, since flupirtine is devoid of the typical side effects of NMDA-receptor antagonists.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  • Bergman H, Wichmann T, DeLong MR (1990) Reversal of experimental parkinsonism by lesions of the subthalamic nucleus. Science 249: 1436–1438

    PubMed  Google Scholar 

  • Birkmayer W, Hornykiewicz O (1961) Der L-3,4-Dioxyphenyalanin (-DOPA)-Effekt bei der Parkinson-Akinese. Wien Klin Wochenschr 73: 787–788

    PubMed  Google Scholar 

  • Block F, Pergande G, Schwarz M (1994) Flupirtine protects against ischaemic retinal dysfunction in rats. NeuroReport 5: 2630–2632

    PubMed  Google Scholar 

  • Brotchie JM, Mitchell IJ, Sambrock MA, Crossman AR (1991) Alleviation of parkinsonism by antagonism of excitatory amino acid transmission in the medial segment of the globus pallidus in rat and primate. Mov Disord 6: 133–138

    PubMed  Google Scholar 

  • Carlsson M, Carlsson A (1989) The NMDA antagonist MK-801 causes marked locomotor stimulation in monoamine-depleted mice. J Neural Transm 75: 221–226

    PubMed  Google Scholar 

  • Carlsson KH, Jurna I (1987) Depression by flupirtine, a novel analgesic agent, of motor and sensory responses of the nociceptive system in the rat spinal cord. Eur J Pharmacol 143: 89–99

    PubMed  Google Scholar 

  • Carlsson M, Svensson A, Carlsson A (1992) Interaction between excitatory amino acids, catecholamines and acetylcholine in the basal ganglia. In: Simon RP (ed) Excitatory amino acids. Thieme, New York, pp 189–194

    Google Scholar 

  • Engber TM, Anderson JJ, Boldry RC (1993) N-methyl-D-aspartate receptor blockade differentially modifies regional cerebral metabolic responses to Dl and D2 dopamine agonists in rats with unilateral 6-hydroxydopamine lesion. Neuroscience 54: 1051–1061

    PubMed  Google Scholar 

  • Fahn S (1992) Adverse effects of levodopa. In: Olanow CW, Lieberman AN (eds) The scientific basis for the treatment of Parkinson's disease. Parthenon, Carnforth, pp 89–112

    Google Scholar 

  • Filion M, Tremblay L (1991) Abnormal spontaneous activity of globus pallidus neurons in monkeys with MPTP-induced parkinsonism. Brain Res 547: 142–151

    PubMed  Google Scholar 

  • Friedel HA, Fitton A (1993) Flupirtine: a review of its pharmacological properties and therapeutic efficacy in pain states. Drugs 45: 548–569

    PubMed  Google Scholar 

  • Greenamyre JT, Eller RV, Zhang Z, Ovadia A, Kurlan R, Gash DM (1994) Antiparkinsonian effects of remacemide hydrochloride, a glutamate antagonist, in rodent and primate models of Parkinson's disease. Ann Neurol 35: 655–661

    PubMed  Google Scholar 

  • Havemann U, Winkler M, Kuschinsky K (1980) Opioid receptors in the caudate nucleus can mediate EMG-recorded rigidity in rats. Naunyn Schmiedebergs Arch Pharmacol 313: 139–144

    PubMed  Google Scholar 

  • Klockgether T, Turski L (1990) NMDA antagonists potentiate antiparkinsonian actions of L-DOPA in monoamine-depleted rats. Ann Neurol 28: 539–546

    PubMed  Google Scholar 

  • Klockgether T, Turski L (1993) Toward an understanding of the role of glutamate in experimental parkinsonism: agonist-sensitive sites in the basal ganglia. Ann Neurol 34: 585–593

    PubMed  Google Scholar 

  • Löschmann PA, Lange KW, Kunow M, Rettig KJ, Jähnig P, Honoré T, Turski L, Wachtel H, Jenner P, Marsden CD (1991) Synergism of the AMPA-antagonist NBQX and the NMDA-antagonist CPP with L-DOPA in models of Parkinson's disease. J Neural Transm [PD-Sect] 3: 203–213

    Google Scholar 

  • Maj J, Sowinska H, Baran L, Samek J (1974) Pharmacological effect of 1,3-dimethyl-5-amino-adamantane, a new adamantane derivative. Eur J Pharmacol 26: 9–14

    PubMed  Google Scholar 

  • Mitchell IJ, Clarke CE, Boyce S (1989) Neural mechanisms underlying parkinsonian symptoms based upon regional uptake of 2-deoxyglucose in monkeys exposed to 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine. Neuroscience 32: 213–226

    PubMed  Google Scholar 

  • Moore R, Bullingham RES, Simpson S, O'Sullivan G, Evans PJD, McQuay J (1983) Comparison of flupirtine maleate and dihydrocodeine in patients following surgery. Br J Anaesth 55: 429–432

    PubMed  Google Scholar 

  • Morelli M, Fenu S, Pinna A, Di Chiara G (1992) Opposite effects of NMDA receptor blockade on dopaminergic D1- and D2-mediated behaviour in the 6-hydroxydopamine model of turning: relationship with c-fos expression. J Pharmacol Exp Ther 260: 402–408

    PubMed  Google Scholar 

  • Nickel B, Jakovlev V, Szelenyi I (1990) Effects of flupirtine, some analgesics and of muscle relaxants on sceletal muscle tone in conscious rats. Arzneimittelforschung/Drug Res 40: 909–911

    Google Scholar 

  • Osborne NN, Pergande G, Block F, Schwarz M (1994) Immunohistochemical evidence for flupirtine acting as an antagonist on the N-methyl-D-aspartate and homocysteic acid-induced release of GABA in the rat retina. Brain Res 667: 291–294

    PubMed  Google Scholar 

  • Osborne NN, Schwarz M, Pergande G (1996) Protection of rabbit retina from ischaemic injury by flupirtine. Invest Ophthalmol Vis Sci 37: 274–280

    PubMed  Google Scholar 

  • Perovic S, Schleger C, Pergande G, Iskric I, Ushijima H, Rytik P, Müller WEG (1994) The triaminopyridine flupirtine prevents cell death in rat cortical cells induced by N-methyl-D-aspartate and gp120 of HIV-1. Eur J Pharmacol 288: 27–33

    PubMed  Google Scholar 

  • Rogawski MA (1993) Therapeutic potential of excitatory amino acid antagonists: channel blockers and 2,3-benzodiazepines. Trends Pharmacol Sci 14: 325–331

    PubMed  Google Scholar 

  • Rupalla K, Cao W, Krieglstein J (1995) Flupirtine protects neurons against excitotoxic or ischemic damage and inhibits the increase in cytosolic Ca2+ concentration. Eur J Pharmacol 294: 469–473

    PubMed  Google Scholar 

  • Schmidt WJ, Bubser M (1989) Anticataleptic effects of N-methyl-D-aspartate antagonist MK-801 in rats. Pharmacol Biochem Behav 32: 621–623

    PubMed  Google Scholar 

  • Schmidt WJ, Bubser M, Hauber W (1992) Behavioural pharmacology of glutamate in the basal ganglia. J Neural Transm 38 [Suppl]: 65–89

    Google Scholar 

  • Scholz E, Diener HC, Noth J, Friedemann H, Dichgans J, Bacher M (1986) Medium and long latency EMG responses in leg muscles: Parkinson's disease. J Neurol Neurosurg Psychiatry 50: 66–70

    Google Scholar 

  • Schwarz M, Block F, Pergande G (1994) N-methyl-D-aspartate (NMDA) mediated muscle relaxant action of flupirtine in rats. NeuroReport 5: 1981–1984

    PubMed  Google Scholar 

  • Schwarz M, Schmitt T, Pergande G, Block F (1995) N-methyl-D-aspartate and α-2-adrenergic mechanisms are involved in the depressant action of flupirtine on spinal reflexes in rats. Eur J Pharmacol 276: 247–255

    PubMed  Google Scholar 

  • Shahani BT, Young RR (1971) Human flexor reflexes. J Neurol Neurosurg Psychiatry 34: 616–627

    PubMed  Google Scholar 

  • Steg G (1964) Efferent muscle innervation and rigidity. Acta Physiol Scand [Suppl] 223: 1–53

    Google Scholar 

  • Timmann D, Plummer C, Schwarz M, Diener HC (1995) Influence of flupirtine on human lower limb reflexes. Electroencephalogr Clin Neurophysiol 97: 184–188

    PubMed  Google Scholar 

Download references

Author information

Author notes

  1. M. Schwarz

    Present address: Department of Neurology, Technical University, Aachen

Authors and Affiliations

  1. Department of Neurology, Technical University, Aachen

    M. Nolden-Koch, J. Purr & F. Block

  2. ASTA Medica Germany, Frankfurt, Federal Republic of Germany

    G. Pergande

Authors
  1. M. Schwarz
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. M. Nolden-Koch
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. J. Purr
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. G. Pergande
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. F. Block
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Cite this article

Schwarz, M., Nolden-Koch, M., Purr, J. et al. Antiparkinsonian effect of flupirtine in monoamine-depleted rats. J. Neural Transmission 103, 581–590 (1996). https://doi.org/10.1007/BF01273155

Download citation

  • Received:

  • Accepted:

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF01273155

Keywords

Search

Navigation